Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter:: An evaluation by a randomized double-blinded trial

被引:38
作者
Nielsen, VE [1 ]
Bonnema, SJ
Boel-Jorgensen, H
Veje, A
Hegedüs, L
机构
[1] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense C, Denmark
关键词
D O I
10.1210/jc.2004-1550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study compares, in a randomized double-blinded design, the expected and the actual absorbed thyroid radioactive dose in response to 0.3 mg recombinant human (rh)TSH (n = 35) or placebo (n = 28) given 24 h before I-131 therapy in patients with nodular goiter (median volume, 69 ml; range, 20-440 ml). The I-131 activity calculation was based on thyroid I-131 uptake (RAIU) at 24 and 96 h after a tracer dose of 0.5 MBq I-131. After I-131 therapy, 24- and 96-h RAIU were repeated allowing a more exact assessment of the actual absorbed thyroid dose. The median I-131 activity was 617 and 632 MBq, respectively, in the rhTSH and the placebo group. At baseline, the 24- and 96-h RAIU and the expected thyroid dose were 32.8 +/- 9.1%, 32.1 +/- 8.2%, and 96.3 +/- 16.3 Gy, respectively, in the rhTSH group and 35.7 +/- 11.8%, 35.2 +/- 11.3%, and 94.1 +/- 18.5 Gy, respectively, in the placebo group (P value not significant between groups). After I-131 therapy, the 24- and 96-h RAIU and the actual absorbed thyroid dose were 46.9 +/- 11.7%, 45.0 +/- 12.1%, and 136.7 +/- 47.9 Gy, respectively, in the rhTSH group and 33.0 +/- 11.4%, 31.0 +/- 11.3%, and 76.9 +/- 27.5 Gy, respectively, in the placebo group (P < 0.001 between groups). Comparing the expected with the actual absorbed thyroid dose, this corresponds to a mean increase of 36.4% (95% confidence interval, 21.3-53.4) in the rhTSH group and a decrease of 21.5% (95% confidence interval, -33.9 to -6.6) in the placebo group (P < 0.001), equivalent to an increase of 73.8% in the absorbed thyroid dose in the rhTSH-treated group. We have thus for the first time shown that stimulation with rhTSH before I-131 therapy not only hinders the decrease in the thyroid RAIU observed with conventional I-131 therapy but in fact also significantly enhances the absorbed thyroid dose. Whether this also leads to a significant increase in goiter size reduction needs additional study.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 22 条
[1]  
Berg GEB, 1996, J NUCL MED, V37, P228
[2]   Management of the nontoxic multinodular goitre:: A European questionnaire study [J].
Bonnema, SJ ;
Bennedbæk, FN ;
Wiersinga, WM ;
Hegedüs, L .
CLINICAL ENDOCRINOLOGY, 2000, 53 (01) :5-12
[3]   MR imaging of large multinodular goiters:: Observer agreement on volume versus observer disagreement on dimensions of the involved trachea [J].
Bonnema, SJ ;
Andersen, PB ;
Knudsen, DU ;
Hegedüs, L .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (01) :259-266
[4]   Management of the nontoxic multinodular goiter:: A north American survey [J].
Bonnema, SJ ;
Bennedbæk, FN ;
Ladenson, PW ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :112-117
[5]   Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome [J].
Catargi, B ;
Leprat, F ;
Guyot, M ;
Valli, N ;
Ducassou, D ;
Tabarin, A .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 141 (02) :117-121
[6]  
deKlerk JMH, 1997, J NUCL MED, V38, P372
[7]  
Duick Daniel S, 2003, Endocr Pract, V9, P204
[8]   REDUCTION OF SIZE OF THYROID WITH RADIOACTIVE IODINE IN MULTINODULAR NON-TOXIC GOITER [J].
HEGEDUS, L ;
HANSEN, BM ;
KNUDSEN, N ;
HANSEN, JM .
BRITISH MEDICAL JOURNAL, 1988, 297 (6649) :661-662
[9]   THE DETERMINATION OF THYROID VOLUME BY ULTRASOUND AND ITS RELATIONSHIP TO BODY-WEIGHT, AGE, AND SEX IN NORMAL SUBJECTS [J].
HEGEDUS, L ;
PERRILD, H ;
POULSEN, LR ;
ANDERSEN, JR ;
HOLM, B ;
SCHNOHR, P ;
JENSEN, G ;
HANSEN, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (02) :260-263
[10]   Management of simple nodular goiter:: Current status and future perspectives [J].
Hegedüs, L ;
Bonnema, SJ ;
Bennedbæk, FN .
ENDOCRINE REVIEWS, 2003, 24 (01) :102-132